BiotechTube
Home/Allgenesis Biotherapeutics/Jack Chang
JC

Jack Chang

Vice President of Finance

Allgenesis Biotherapeutics

Therapeutic Areas

OphthalmologyRetinal DiseasesOcular Surface Diseases

Allgenesis Biotherapeutics Pipeline

DrugIndicationPhase
AG-73305Diabetic Macular Edema, neovascular AMD, other retinal diseasesPhase 2a
AG-80308Dry Eye Disease, ocular inflammationPhase 1b
AG-86893Pterygium, Dry EyePhase 2/3

Leadership Team at Allgenesis Biotherapeutics

MC
Madhu Cherukury
Chief Executive Officer
TN
Tan Nguyen
Vice President of Research & Development
View full Allgenesis Biotherapeutics profile